胰岛素样生长因子结合蛋白-4：肺动脉高压突破性生物标志物的探索 - Suppr

Suppr

超能文献

Insulin-like growth factor binding protein-4: The quest for the breakthrough biomarker in pulmonary arterial hypertension.

作者信息

Estrada Rodolfo A, Sahay Sandeep

机构信息

Division of Pulmonary Diseases and Critical Care Medicine UT Health San Antonio Texas USA.

Division of Pulmonary, Critical Care & Sleep Medicine Houston Methodist Hospital Houston Texas USA.

出版信息

Pulm Circ. 2023 Jun 20;13(2):e12252. doi: 10.1002/pul2.12252. eCollection 2023 Apr.

DOI:10.1002/pul2.12252

PMID:37346965

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10281014/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b15b/10281014/14f1a6de50ce/PUL2-13-e12252-g001.jpg

相似文献

Insulin-like growth factor binding protein-4: The quest for the breakthrough biomarker in pulmonary arterial hypertension.胰岛素样生长因子结合蛋白-4：肺动脉高压突破性生物标志物的探索

Pulm Circ. 2023 Jun 20;13(2):e12252. doi: 10.1002/pul2.12252. eCollection 2023 Apr.

Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.胰岛素样生长因子结合蛋白-2：一种新的循环标志物，可反映肺动脉高压严重程度和生存率。

BMC Med. 2020 Oct 6;18(1):268. doi: 10.1186/s12916-020-01734-3.

Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.儿童肺动脉高压：胰岛素样生长因子结合蛋白 2 是一种与疾病严重程度和生存相关的新型标志物。

Pediatr Res. 2020 Dec;88(6):850-856. doi: 10.1038/s41390-020-01113-x. Epub 2020 Sep 14.

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension.较高的血浆成纤维细胞生长因子23水平与肺动脉高压的较高风险特征相关。

Pulm Circ. 2019 Dec 27;9(4):2045894019895446. doi: 10.1177/2045894019895446. eCollection 2019 Oct-Dec.

Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension.肺动脉高压中的血浆胰岛素样生长因子结合蛋白 1。

Scand Cardiovasc J. 2021 Feb;55(1):35-42. doi: 10.1080/14017431.2020.1782977. Epub 2020 Jun 29.

Insulin-like growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy.动脉高血压中的胰岛素样生长因子结合蛋白：与左心室肥厚的关系。

J Hypertens. 1995 Mar;13(3):349-55.

Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.肝癌衍生生长因子可预测肺动脉高压的疾病严重程度和生存率。

Am J Respir Crit Care Med. 2016 Nov 15;194(10):1264-1272. doi: 10.1164/rccm.201512-2498OC.

The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left.

Heart. 2016 Mar;102(5):335-6. doi: 10.1136/heartjnl-2015-309070.

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.CTLA-4 表达是特发性肺动脉高压有前途的生物标志物，并可区分肺动脉高压的类型。

Int J Mol Sci. 2022 Dec 14;23(24):15910. doi: 10.3390/ijms232415910.

Can serum 8-hydroxy-2'-deoxyguanosine levels reflect the severity of pulmonary arterial hypertension?血清 8-羟基-2'-脱氧鸟苷水平能否反映肺动脉高压的严重程度？

Rev Assoc Med Bras (1992). 2021 Oct;67(10):1437-1442. doi: 10.1590/1806-9282.20210640.

本文引用的文献

Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survival.胰岛素样生长因子结合蛋白-4：肺动脉高压严重程度和生存的新指标。

Pulm Circ. 2023 May 3;13(2):e12235. doi: 10.1002/pul2.12235. eCollection 2023 Apr.

Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.循环炎症和血管生成标志物与肺动脉高压各亚型的临床结局。

J Heart Lung Transplant. 2023 Feb;42(2):173-182. doi: 10.1016/j.healun.2022.10.026. Epub 2022 Nov 7.

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。

Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.肺动脉高压的现代时代的死亡率：来自肺动脉高压协会注册的早期洞察。

J Am Heart Assoc. 2022 May 3;11(9):e024969. doi: 10.1161/JAHA.121.024969. Epub 2022 Apr 27.

BMC Med. 2020 Oct 6;18(1):268. doi: 10.1186/s12916-020-01734-3.

Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies.当前心血管疾病中与胰岛素样生长因子结合蛋白相关的生物标志物研究——我们在临床研究中需要更多结构和功能信息。

Front Endocrinol (Lausanne). 2018 Jul 16;9:388. doi: 10.3389/fendo.2018.00388. eCollection 2018.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.肺动脉高压死亡率：2015 年欧洲肺动脉高压指南风险分层模型预测。

Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.肺动脉高压患者的血浆蛋白质组分析：一项观察性队列研究。

Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.IGFBP-4 的抗血管生成和抗肿瘤作用与其抗组织蛋白酶 B 的活性有关。

Neoplasia. 2013 May;15(5):554-67. doi: 10.1593/neo.13212.

NTproBNP: an important biomarker in cardiac diseases.NT-proBNP：心脏疾病的重要生物标志物。

Curr Top Med Chem. 2013;13(2):82-94. doi: 10.2174/1568026611313020002.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验